Overview of piperlongumine analogues and their therapeutic potentialPeng Zhu, Yong Ling, Jianqiang Qian et al.|European Journal of Medicinal Chemistry|2021Cited by 62
A Derivative of Piperlongumine and Ligustrazine as a Potential Thioredoxin Reductase Inhibitor in Drug-Resistant Hepatocellular CarcinomaJianqiang Qian, Yong Ling, Chi Meng et al.|Journal of Natural Products|2021Cited by 28
Recent development of BTK-based dual inhibitors in the treatment of cancersFansheng Ran, Yong Ling, Yun Liu et al.|European Journal of Medicinal Chemistry|2022Cited by 28
TME-targeting theranostic agent uses NIR tracking for tumor diagnosis and surgical resection and acts as chemotherapeutic showing enhanced efficiency and minimal toxicityZhongyuan Xu, Yong Ling, Jianqiang Qian et al.|Theranostics|2022Cited by 20
Redox-Activatable Theranostic Co-Prodrug for Precise Tumor Diagnosis and Selective Combination ChemotherapyJianqiang Qian, Yong Ling, Zhongyuan Xu et al.|Journal of Medicinal Chemistry|2022Cited by 15